| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8527b9e7a75d6fc0fa63772b0a69f3c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6855
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6829
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 |
| filingDate |
2018-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71a3358ebdaa2bfa84a68bbaa1b501eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3876bee4a4a13dd3f4cd7a1bd17779b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ae2ddc535a633ce145670097c53783b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50a3a0609481ca52954a87c7de77918b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30f675a75e2fbc863a78eec821099fe5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6af210f934b8270987cd28cce2ab6984 |
| publicationDate |
2018-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018206715-A2 |
| titleOfInvention |
Modified microcystins and nodularins |
| abstract |
The invention relates to a compound, which comprises the cytotoxic agents microcystin and nodularin. More specifically, the invention is related to a modified microcystin and/or nodularin compound comprising one or more modified substrates, wherein one or more modified substrates comprise an anchor group directly accessible or transformable for use in conjugation chemistry (incl. click chemistry), for the attachment of a targeting moiety. This invention is in the field of cancer treatment. It is in the field of toxins for use in cancer treatment. The modified cytotoxic agents may be used for the therapy of various diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110606876-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110606876-A |
| priorityDate |
2017-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |